Background: The fractional excretion of urea (FeUrea) may result in more reliable in the determination of renal function than sodium in the presence of oliguric azotemia; however, its usefulness remains controversial, perhaps due to an evolving understanding of urea transport within the kidney. Methods: This was a prospective observational study of 100 consecutive patients referred to the nephrology service for azotemic oliguria. Multiple clinical variables were analyzed to determine variables responsible for the differences between the FeUrea and fractional excretion of sodium (FeNa) in the ability to distinguish pre-renal azotemia from intrinsic renal disease. Results: Overall, the FeUrea was more accurate (95 vs. 54%, p < 0.0001), yet both tests accurately detected the presence of intrinsic renal disease (FeNa 75%, FeUrea 85%, p = NS). The FeUrea performed significantly better (98 to 49%, p < 0.0001) in detecting pre-renal azotemia, and that advantage came exclusively in patients taking diuretics (p < 0.0001); however, 4/5 cases incorrectly detected by the FeUrea were correctly detected by the FeNa. All 4 cases had infection. Conclusion: The FeUrea appears more accurate in patients receiving diuretics; however, the FeNa may have an advantage in patients with infection.

1.
Espinel CH: The FeNa test. Use in the differential diagnosis of acute renal failure. JAMA 1976;236:579–581.
2.
Rothberg AD, Andronikou S: Effect of tobramycin on fractional sodium excretion in neonates. Pediatr Pharmacol (New York) 1984;4:49–52.
3.
Corwin HL, Schreiber MJ, Fang LS: Low fractional excretion of sodium. Occurrence with hemoglobinuric- and myoglobinuric-induced acute renal failure. Arch Intern Med 1984;144:981–982.
4.
Vaz AJ: Low fractional excretion of urine sodium in acute renal failure due to sepsis. Arch Intern Med 1983;143:738–739.
5.
Godon JP: Evidence of increased proximal sodium and water reabsorption in experimental glomerulonephritis. Role of a natriuretic factor of renal origin. Nephron 1978;21:146–154.
6.
Fang LS, Sirota RA, Ebert TH, Lichtenstein NS: Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med 1980;140:531–533.
7.
Hoffman LM, Suki WN: Obstructive uropathy mimicking volume depletion. JAMA 1976;236:2096–2097.
8.
Nanji AJ: Increased fractional excretion of sodium in prerenal azotemia: need for careful interpretation. Clin Chem 1981;27:1314–1315.
9.
Miller PD, Krebs RA, Neal BJ, McIntyre DO: Polyuric prerenal failure. Arch Intern Med 1980;140:907–909.
10.
Schück O: Fractional sodium excretion in patients with chronic renal failure with respect to the therapy Nephron 1982;30:95–96.
11.
Kaplan AA, Kohn OF: Fractional excretion of urea as a guide to renal dysfunction. Am J Nephrol 1992;12:49–54.
12.
Zarich S, Fang LS, Diamond JR: Fractional excretion of sodium. Exceptions to its diagnostic value. Arch Intern Med 1985;145:108–112.
13.
Decaux G, Dumont I, Naeije N, Mols P, Melot C, Mockel J: High uric acid and urea clearance in cirrhosis secondary to increased ‘effective vascular volume’. Am J Med 1982;73:328–334.
14.
van Olden RW, Guchelaar HJ, Struijk DG, Krediet RT, Arisz L: Acute effects of high-dose furosemide on residual renal function in CAPD patients. Perit Dial Int 2003;23:339–347.
15.
Carvounis CP, Nisar S, Guro-Razuman S: Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002;62:2223–2229.
16.
Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB: The evolution of the fractional excretion of urea as a diagnostic tool in oliguric states. Am J Kidney Dis 2008;51:869–870.
17.
Pepin MN, Bouchard J, Legault L, Ethier J: Diagnostic performance of fractional excretion of urea and fractional excretion of sodium in the evaluations of patients with acute kidney injury with or without diuretic treatment. Am J Kidney Dis 2007;50:566–573.
18.
Schmidt C, Hocherl K, Bucher M: Cytokine-mediated regulation of urea transporters during experimental endotoxemia. Am J Physiol Renal Physiol 2007;292:F1479–F1489.
19.
Lewis WH, Alving AS: Changes with age in renal function in adult men. I. Clearance of urea. II. Amount of urea nitrogen in the blood. III. Concentrating ability of the kidneys. Am J Physiol 1938;123:500–515.
20.
Musch W, Verfaillie L, Decaux G: Age-related increase in plasma urea level and decrease in fractional urea excretion: clinical application in the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 2006;1:909–914.
21.
Yano Y, Rodrígues AC Jr, de Bragança AC, Andrade LC, Magaldi AJ: PKC stimulated by glucagon decreases UT-A1 urea transporter expression in rat IMCD. Pflügers Arch 2008;456:1229–1237.
22.
Decaux G, Prospert F, Namias B, Schlesser M, Soupart A: Raised urea clearance in cirrhotic patients with high uric acid clearance is related to low salt excretion. Gut 1992;33:1105–1108.
23.
Lim SW, Li C, Sun BK, Han KH, Kim WY, Oh YW, Lee JU, Kador PF, Knepper MA, Sands JM, Kim J, Yang CW: Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney. Am J Physiol Renal Physiol 2004;287:F139–F151.
24.
Shannon JA: Glomerular filtration and urea excretion in relation to urine flow in the dog. Am J Physiol 1936;117:206–225.
25.
Shannon JA: Urea excretion in the normal dog during forced diuresis. Am J Physiol 1938;122:782–787.
26.
Diskin CJ: Creatinine and glomerular filtration rate: evolution of an accommodation. Ann Clin Biochem 2007;44:16–19.
27.
Diskin CJ: More on case 7-2006. N Engl J Med 2006;355:1502–1503.
28.
Levy GB: Determination of sodium with ion-selective electrodes. Clin Chem 1981;27:1435–1438.
29.
Vogesser M, Jacob K: B-type natriuretic peptide (BNP)-validation of an immediate response assay. Clin Lab 2001;47:29–33.
30.
Diskin C, Dansby LM, Radcliff L, Carter TB, Graves E, Graves A: Recurrent hyponatremia after intrathecal methotrexate not related to antidiuretic hormone: is a natriuretic peptide activated? Am J Med Sci 2006;331:37–39.
31.
Chasis H, Smith HW: The excretion of urea in normal man and in subjects with glomerulonephritis. J Clin Invest 1938;17:347–358.
32.
Dole VP: Back diffusion of urea in the mammalian kidney. Am J Physiol 1943;139:504–513.
33.
Dal Canton A, Fuiano G, Conte G, Terribile M, Sabbatini M, Cianciaruso B, Andreucci VE: Mechanism of increased plasma urea after diuretic therapy in uraemic patients. Clin Sci (Lond) 1985;68:255–261.
34.
Brosius FC, Lau K: Low fractional excretion of sodium in acute renal failure: role of timing of the test and ischemia. Am J Nephrol 1986;6:450–457.
35.
Daly TM, Kempe KC, Scott MG: Bouncing creatinine levels. N Engl J Med 1996;334:1749–1750.
36.
van Olden RW, Guchelaar HJ, Struijk DG, Krediet RT, Arisz L: Acute effects of high-dose furosemide on residual renal function in CAPD patients. Perit Dial Int 2003;23:339–347.
37.
Hoffmann U, Fischereder M, Kruger B, et al: The value of N-acetyl-cysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004;15:407–410.
38.
Fröhlich O, Aggarwal D, Klein JD, Kent KJ, Yang Y, Gunn RB, Sands JM: Stimulation of UT-A1-mediated transepithelial urea flux in MDCK cells by lithium. Am J Physiol Renal Physiol 2008;294:F518–F524
39.
Jamison RL, Kriz, W: Urinary Concentrating Mechanism. New York, Oxford University Press, 1982, pp 340.
40.
Fenton RA, Knepper MA: Urea and renal function in the 21st century: insights from knockout mice. J Am Soc Nephrol 2007;18:679–688.
41.
Inoue H, Jackson SD, Vikulina T, Klein JD, Tomita K, and Bagnasco SM: Identification and characterization of a Kidd antigen/UT-B urea transporter expressed in human colon. Am J Physiol Cell Physiol 2004;287:C30–C35.
42.
Smith CP, Potter EA, Fenton RA, Stewart GS: Characterization of a human colonic cDNA encoding a structurally novel urea transporter, hUT-A6. Am J Physiol Cell Physiol 2004;287:C1087–C1093.
43.
Inoue H, Kozlowski SD, Klein JD, Bailey JL, Sands JM, Bagnasco SM: Regulated expression of renal and intestinal UT-B urea transporter in response to varying urea load. Am J Physiol Renal Physiol 2005;289:F451–F458.
44.
Liaño F, Pascual J: Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996;50:811–818.
45.
Brady HR, Brenner BM, Clarkson MR, Lieberthal W: Acute renal failure; in Brenner BM (ed): The Kidney. Philadelphia, WB Saunders, 2000, pp 1201–1262.
46.
Haase M, Haase-Fielitz A, Ratnaike S, Reade MC, Bagshaw SM, Morgera S, Dragun D, Bellomo R: N-Acetylcysteine does not artifactually lower plasma creatinine concentration. Nephrol Dial Transplant 2008;23:1581–1587.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.